Report cover image

North America Insulin Market for Type 1 and Type 2 Diabetes

Publisher Data Bridge Market Research
Published Apr 01, 2025
Length 350 Pages
SKU # DAABD20406730

Description

North America insulin market for type 1 and type 2 diabetes is expected to reach USD 10.58 billion by 2032 from USD 8.38 billion in 2024, growing at a substantial CAGR of 3.0% in the forecast period of 2025 to 2032.
Market Segmentation:
North America Market for Type 1 And Type 2 Diabetes Segmentation, Type (Type 2 Diabetes and Type 1 Diabetes), Product Type (Long Acting Insulin, Rapid-Acting Insulin, Short Acting Insulin, and Others), Absorption Site (Basal, Bolus, and Others), Age Group (Adult Patients, Geriatric Patients, and Pediatric Patients), Source (Analog Insulin, Human Insulin, and Others), Delivery Method (Insulin Pens, Vial & Syringe, Insulin Pumps, Inhalable Insulin, and Implantable Insulin Delivery Systems), Gender (Male and Female), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Diabetes Clinics & Specialty Pharmacies), By Countries (U.S., Canada, and Mexico)- Industry Trends and Forecast to 2032



Overview of North America Insulin Market for Type 1 and Type 2 Diabetes Dynamics:


Driver

• Rising prevalence of diabetes
Restraint

• Adverse effects of high dosage of insulin

Opportunity

• Advancements in insulin formulation and delivery technologies
Market Players:

The key market players operating in the North America insulin market for type 1 and type 2 diabetes are listed below:

• Novo Nordisk A/S (Denmark)
• Eli Lilly and Company (U.S.)
• Sanofi (France)
• Biocon (India)
• Lupin (India)
• Shanghai Fosun Wanbang (Jiangsu)
• Pharmaceutical Group Co., Ltd. (China)
• Diasome Pharmaceuticals, Inc. (U.S.)
• SciGen Pte. Ltd. (Singapore)
• Wockhardt (India)
• MJ Biopharma Pvt. Ltd. (India)
• Oramed Pharmaceuticals (U.S.)
• Adocia (France)
• Nektar Therapeutics (U.S.)



Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Oral Insulin Market For Type 1 And Type 2 Diabetes
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porters Five Forces Analysis
4.3 Epidemiology
4.4 Industry Insights
4.5 Key Marketing Strategies For The North America Oral Insulin Market (Type 1 & Type 2 Diabetes)
4.6 Mergers And Acquisition
4.7 Pipeline Anlysis
5 Regulatory
5.1 Regulatory Framework For The Asia-pacific Oral Insulin Market For Type 1 And Type 2 Diabetes
5.1.1 Regulatory Approval Process
5.1.2 Geographies’ Ease Of Regulatory Approval
5.1.3 Regulatory Approval Pathways (Country-wise)
5.1.4 Licensing And Registration
5.1.5 Post-marketing Surveillance
5.1.6 Good Manufacturing Practices (Gmps) Guidelines
5.2 Regulatory Framework For The North America Oral Insulin Market For Type 1 And Type 2 Diabetes
5.2.1 Regulatory Approval Process
5.2.2 Geographies’ Ease Of Regulatory Approval
5.2.3 Regulatory Approval Pathways (Country-wise)
5.2.4 Licensing And Registration
5.2.5 Post-marketing Surveillance
5.2.6 Good Manufacturing Practices (Gmps) Guidelines
5.3 Regulatory Framework For The South America Oral Insulin Market For Type 1 And Type 2 Diabetes
5.3.1 Regulatory Approval Process
5.3.2 Geographies’ Ease Of Regulatory Approval
5.3.3 Regulatory Approval Pathways (Country-wise)
5.3.4 Licensing And Registration
5.3.5 Post-marketing Surveillance
5.3.6 Good Manufacturing Practices (Gmps) Guidelines
5.4 Regulatory Framework For The Europe Oral Insulin Market For Type 1 And Type 2 Diabetes
5.4.1 Regulatory Approval Process
5.4.2 Geographies’ Ease Of Regulatory Approval
5.4.3 Regulatory Approval Pathways (Country-wise)
5.4.4 Licensing And Registration
5.4.5 Post-marketing Surveillance
5.4.6 Good Manufacturing Practices (Gmps) Guidelines
5.5 Regulatory Framework For The Middle East & Africa (Mea) Oral Insulin Market For Type 1 And Type 2 Diabetes
5.5.1 Regulatory Approval Process
5.5.2 Geographies’ Ease Of Regulatory Approval
5.5.3 Regulatory Approval Pathways (Country-wise)
5.5.4 Licensing And Registration
5.5.5 Post-marketing Surveillance
5.5.6 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview
6.1 Drivers
6.1.1 Growing Incidence Of Diabetes Worldwide
6.1.2 Growing Geriatric Population Encouraging Demand For Non-invasive Diabetes Solutions
6.1.3 Advancements In Oral Insulin Formulations
6.1.4 Enhanced Patient Compliance And Convenience With Oral Insulin
6.2 Restraints
6.2.1 Adverse Effects Of High Dosage Of Insulin
6.2.2 High Production And Development Costs Associated With Insulin
6.3 Opportunities
6.3.1 Advancements In Oral Insulin Delivery Technologies
6.3.2 Revolutionizing Diabetes Management With Needle-free Oral Insulin
6.3.3 Increasing Pharmaceutical Investments And Strategic Collaborations
6.4 Challenges
6.4.1 Insulin Accessibility Challenges In Rural And Underserved Regions
6.4.2 Limited Shelf Life Associated With Oral Insulin
7 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Type
7.1 Overview
7.2 Type 2 Diabetes
7.3 Type 1 Diabetes
8 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Technology
8.1 Overview
8.2 Polymeric Nanoparticles
8.3 Nanoparticle-based Delivery Systems
8.4 Encapsulation Technology
8.5 Lipid-based Nanocarriers
9 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Product Type
9.1 Overview
9.2 Capsules
10 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Absorption Site
10.1 Overview
10.2 Intestinal
11 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Formulation Type
11.1 Overview
11.2 Enteric-coated Oral Insulin
12 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Age Group
12.1 Overview
12.2 Adult Patients
12.3 Geriatric Patients
12.4 Pediatric Patients
13 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Gender
13.1 Overview
13.2 Male
13.3 Female
14 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Distribution Channel
14.1 Overview
14.2 Retail Pharmacies
14.3 Hospital Pharmacies
14.4 Online Pharmacies
14.5 Diabetes Clinics & Specialty Pharmacies
15 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region
15.1 North America
15.1.1 U.S.
15.1.2 Canada
15.1.3 Mexico
16 Company Profile
16.1 Aphios Corporation
16.1.1 Company Snapshot
16.1.2 Pipeline Portfolio
16.1.3 Recent Updates
16.2 Biocon
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Pipeline Product Portfolio
16.2.4 Recent Development
16.3 Diabetology Ltd
16.3.1 Company Snapshot
16.3.2 Pipeline Portfolio
16.3.3 Recent Updates
16.4 Endo Axiom
16.4.1 Company Snapshot
16.4.2 Pipeline Portfolio
16.4.3 Recent Developments
16.5 Murli Krishna Pharma
16.5.1 Company Snapshot
16.5.2 Pipeline Portfolio
16.5.3 Recent Updates
16.6 Niedlfree
16.6.1 Company Snapshot
16.6.2 Pipeline Portfolio
16.6.3 Recent Updates
16.7 Oramed
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Pipeline Product Portfolio
16.7.4 Recent Development
16.8 Transgene Biotek Limited
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Pipeline Portfolio
16.8.4 Recent Development
17 Questionnaire
18 Related Reports
List Of Tables
Table 1 North America Clinical Trial Market For Oral Insulin Market For Type 1 And Type 2 Diabetes
Table 2 Distribution Of Products And Projects By Phase North America Oral Insulin Market For Type 1 And Type 2 Diabetes
Table 3 Distribution Of Projects By Therapeutic Area And Phase North America Oral Insulin Market For Type 1 And Type 2 Diabetes
Table 4 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Type, 2018-2032 (Usd Thousand)
Table 5 North America Type 2 Diabetes In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 6 North America Type 1 Diabetes In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 7 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Technology, 2018-2032 (Usd Thousand)
Table 8 North America Polymeric Nanoparticles In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 9 North America Nanoparticle-based Delivery Systems In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 10 North America Encapsulation Technology In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 11 North America Lipid-based Nanocarriers In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 12 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Product Type, 2018-2032 (Usd Thousand)
Table 13 North America Capsules In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 14 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Product Type, 2018-2032 (Usd Thousand)
Table 15 North America Intestinal In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 16 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Formulation Type, 2018-2032 (Usd Thousand)
Table 17 North America Enteric-coated Oral Insulin In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 18 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Age Group, 2018-2032 (Usd Thousand)
Table 19 North America Adult Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 20 North America Geriatric Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 21 North America Pediatric Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 22 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Gender, 2018-2032 (Usd Thousand)
Table 23 North America Male In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 24 North America Female In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 25 North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 26 North America Retail Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 27 North America Hospital Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 28 North America Online Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 29 North America Diabetes Clinics & Specialty Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand)
Table 30 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Country, 2028-2032 (Usd Thousand)
List Of Figures
Figure 1 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Segmentation
Figure 2 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Data Triangulation
Figure 3 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Droc Analysis
Figure 4 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: North America Vs Regional Market Analysis
Figure 5 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Company Research Analysis
Figure 6 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Interview Demographics
Figure 7 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Dbmr Market Position Grid
Figure 8 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Segmentation
Figure 9 North America Oral Insulin Market For Type 1 And Type 2 Diabetes Executive Summary
Figure 10 Strategic Decisions
Figure 11 Two Segments Comprise The North America Oral Insulin Market For Type 1 And Type 2 Diabetes, By Type
Figure 12 Growing Incidence Of Diabetes Worldwide Is Expected To Drive The North America Oral Insulin Market For Type 1 And Type 2 Diabetes Growth In The Forecast Period Of 2026 To 2032
Figure 13 Type 2 Segment Is Expected To Account For The Largest Share Of The North America Oral Insulin Market For Type 1 And Type 2 Diabetes In The Forecast Period Of 2026 & 2032
Figure 14 Top 10 Countries By The Number Of Adults With Diabetes In 2021
Figure 15 North America Healthcare Expenditure For Diabetes
Figure 16 Number Of People With Diabetes In 2045 (Millions)
Figure 17 Droc Analysis
Figure 18 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, 2024
Figure 19 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, 2025 To 2032 (Usd Thousand)
Figure 20 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, Cagr (2025- 2032)
Figure 21 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, Lifeline Curve
Figure 22 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, 2024
Figure 23 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, 2025 To 2032 (Usd Thousand)
Figure 24 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, Cagr (2025- 2032)
Figure 25 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, Lifeline Curve
Figure 26 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, 2024
Figure 27 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, 2025 To 2032 (Usd Thousand)
Figure 28 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, Cagr (2025- 2032)
Figure 29 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, Lifeline Curve
Figure 30 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, 2024
Figure 31 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, 2025 To 2032 (Usd Thousand)
Figure 32 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, Cagr (2025- 2032)
Figure 33 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, Lifeline Curve
Figure 34 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, 2024
Figure 35 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, 2025 To 2032 (Usd Thousand)
Figure 36 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, Cagr (2025- 2032)
Figure 37 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, Lifeline Curve
Figure 38 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, 2024
Figure 39 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, 2025 To 2032 (Usd Thousand)
Figure 40 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, Cagr (2025- 2032)
Figure 41 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, Lifeline Curve
Figure 42 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, 2024
Figure 43 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, 2025 To 2032 (Usd Thousand)
Figure 44 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, Cagr (2025- 2032)
Figure 45 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, Lifeline Curve
Figure 46 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, 2024
Figure 47 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, 2025 To 2032 (Usd Thousand)
Figure 48 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, Cagr (2025- 2032)
Figure 49 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, Lifeline Curve
Figure 50 North America Oral Insulin Market For Type 1 And Type 2 Diabetes: Snapshot

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us